United States Pharmaceuticals

Inkine Pharmaceutical Company Inc (INKP)

Track

Ticker: INKP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
STAGNARO THOMAS P Non-Executive Director
Transaction date
Planned sale
Price
155.58
Quantity 60,708 +43.8%
Value US$3,816,238
STAGNARO THOMAS P Non-Executive Director
Transaction date
Planned sale
Price
293.13
Quantity 6,071 +0.1%
Value US$3,072,415
LESHUFY J R Non-Executive Director
Transaction date
Sale
Price
430.88
Quantity 31,337 +45.4%
Value US$1,718,292
LESHUFY J R Non-Executive Director
Transaction date
Sale
Price
5.43
Quantity 5,200 -21.1%
Value US$28,236
LESHUFY J R Non-Executive Director
Transaction date
Sale
Price
5.60
Quantity 300 -1.2%
Value US$1,680
HARRAL WILLIAM III Non-Executive Director
Transaction date
Purchase
Price
5.25
Quantity 10,000 +100.0%
Value US$52,500
APPLE ROBERT F Chief Operating and Financial Executive Director
Transaction date
Sale
Price
5.30
Quantity 90,000 -94.7%
Value US$477,000
LESHUFY J R
Transaction date
Sale
Price
5.59
Quantity 2,400 -11.8%
Value US$13,416
LESHUFY J R
Transaction date
Sale
Price
5.58
Quantity 1,100 -5.1%
Value US$6,138
LESHUFY J R
Transaction date
Sale
Price
5.59
Quantity 2,000 -8.5%
Value US$11,180
LESHUFY J R
Transaction date
Sale
Price
5.58
Quantity 1,500 -6.0%
Value US$8,370
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2005-01-05 2005-01-03 PlS Planned sale STAGNARO THOMAS P Non-Executive Director
60,708 +43.8%
155.58
US$3,816,238 		60,708 +43.8% 155.58 US$3,816,238
2004-12-17 2004-12-15 PlS Planned sale STAGNARO THOMAS P Non-Executive Director
6,071 +0.1%
293.13
US$3,072,415 		6,071 +0.1% 293.13 US$3,072,415
2004-12-03 2004-12-02 S Sale LESHUFY J R Non-Executive Director
31,337 +45.4%
430.88
US$1,718,292 		31,337 +45.4% 430.88 US$1,718,292
2004-12-03 2004-12-01 S Sale LESHUFY J R Non-Executive Director
5,200 -21.1%
5.43
US$28,236 		5,200 -21.1% 5.43 US$28,236
2004-11-22 2004-11-17 S Sale LESHUFY J R Non-Executive Director
300 -1.2%
5.60
US$1,680 		300 -1.2% 5.60 US$1,680
2004-11-12 2004-11-12 B Purchase HARRAL WILLIAM III Non-Executive Director
10,000 +100.0%
5.25
US$52,500 		10,000 +100.0% 5.25 US$52,500
2004-11-12 2004-11-09 S Sale APPLE ROBERT F

Chief Operating and Financial

Executive Director
90,000 -94.7%
5.30
US$477,000 		90,000 -94.7% 5.30 US$477,000
2004-02-09 2004-02-06 S Sale LESHUFY J R
2,400 -11.8%
5.59
US$13,416 		2,400 -11.8% 5.59 US$13,416
2004-02-09 2004-02-04 S Sale LESHUFY J R
1,100 -5.1%
5.58
US$6,138 		1,100 -5.1% 5.58 US$6,138
2004-02-09 2004-02-03 S Sale LESHUFY J R
2,000 -8.5%
5.59
US$11,180 		2,000 -8.5% 5.59 US$11,180
2004-02-09 2004-02-02 S Sale LESHUFY J R
1,500 -6.0%
5.58
US$8,370 		1,500 -6.0% 5.58 US$8,370
Explore more

More insider trading research around Inkine Pharmaceutical Company Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America